CID 146683158

Atratumycin

Structural Information

Molecular Formula
C68H84N12O16
SMILES
C[C@@H]1[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](C(=O)NCC(=O)N[C@@H](C(=O)N[C@@H](C(=O)O1)CC3=CC=C(C=C3)O)CC(C)C)C(C)C)[C@H](C4=CC=CC=C4)O)CC(=O)N)CC5=CNC6=CC=CC=C65)CO)NC(=O)/C=C/C7=CC=CC=C7C
InChI
InChI=1S/C68H84N12O16/c1-36(2)29-47-60(87)75-50(30-40-22-25-44(82)26-23-40)68(95)96-39(6)57(77-54(84)27-24-41-16-11-10-15-38(41)5)66(93)76-51(35-81)63(90)73-48(31-43-33-70-46-20-13-12-19-45(43)46)61(88)74-49(32-53(69)83)62(89)79-58(59(86)42-17-8-7-9-18-42)67(94)80-28-14-21-52(80)64(91)78-56(37(3)4)65(92)71-34-55(85)72-47/h7-13,15-20,22-27,33,36-37,39,47-52,56-59,70,81-82,86H,14,21,28-32,34-35H2,1-6H3,(H2,69,83)(H,71,92)(H,72,85)(H,73,90)(H,74,88)(H,75,87)(H,76,93)(H,77,84)(H,78,91)(H,79,89)/b27-24+/t39-,47-,48+,49-,50-,51+,52+,56-,57+,58+,59+/m1/s1
InChIKey
UFPVKIKINBECRQ-CNSCIBEJSA-N
Compound name
(E)-N-[(3S,6R,9S,12S,15S,16R,19R,22R,28R,31S)-6-(2-amino-2-oxoethyl)-12-(hydroxymethyl)-3-[(S)-hydroxy(phenyl)methyl]-19-[(4-hydroxyphenyl)methyl]-9-(1H-indol-3-ylmethyl)-16-methyl-22-(2-methylpropyl)-2,5,8,11,14,18,21,24,27,30-decaoxo-28-propan-2-yl-17-oxa-1,4,7,10,13,20,23,26,29-nonazabicyclo[29.3.0]tetratriacontan-15-yl]-3-(2-methylphenyl)prop-2-enamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

2
References

3
Patents

1324.6128 Da
Monoisotopic Mass

4.0
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 1325.6201 297.3
[M+Na]+ 1347.6020 302.2
[M-H]- 1323.6055 290.0
[M+NH4]+ 1342.6466 295.7
[M+K]+ 1363.5760 283.4
[M+H-H2O]+ 1307.6101 265.0
[M+HCOO]- 1369.6110 295.5
[M+CH3COO]- 1383.6267 297.4
[M+Na-2H]- 1345.5875 300.8
[M]+ 1324.6123 313.9
[M]- 1324.6133 313.9
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe